Clinical trial
Phase I Clinical Study of Meningococcal Group ACYW135 Conjugate Vaccine
NCT04236960 is registered in ClinicalTrials.gov with Walvax Biotechnology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Clinical Study of Meningococcal Group ACYW135 Conjugate Vaccine
- Lead sponsor
- Walvax Biotechnology Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 17, 2018
- Completion date
- November 28, 2019
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.